Peek into the Process

A series of articles in the Journal of the American Medical Association this week examines the US Food and Drug Administration's approval process.

One paper from a Yale University School of Medicine-based group looks at the evidence supporting FDA's decisions to approve nearly 190 drugs between 2005 and 2012. Joseph Ross, an assistant professor of medicine at Yale, and his colleagues report that the clinical trial evidence justifying each approval varies in quality.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.